Improving Access to Overdose Treatment

The purpose of this program is to expand access to naloxone and other Food and Drug Administration (FDA) approved overdose reversal medications for emergency treatment of known or suspected opioid overdose.

The recipients will collaborate with other prescribers at the community level to implement


trainings on policies, procedures, and models of care for prescribing, co-prescribing, and expanding access to naloxone and other FDA-approved overdose reversal medications to the specified population of focus (i.e., rural or urban).
Agency: Department of Health and Human Services

Office: Substance Abuse and Mental Health Services Adminis

Estimated Funding: $1,400,000


Relevant Nonprofit Program Categories





Obtain Full Opportunity Text:
Improving Access to Overdose Treatment

Additional Information of Eligibility:
Eligibility is limited to FQHCs (as defined in section 1861(aa) of the Social Security Act), opioid treatment programs as defined under part 8 of title 42, Code of Federal Regulations, and practitioners dispensing narcotic drugs pursuant to section 303(g) of the Controlled Substances Act (including secondary and higher education settings).

Full Opportunity Web Address:
https://www.samhsa.gov/grants/grant-announcements/ti-23-004

Contact:


Agency Email Description:
FOACSAT@samhsa.hhs.gov

Agency Email:


Date Posted:
2023-01-23

Application Due Date:


Archive Date:
2023-04-23



Social Entrepreneurship
Spotlight



Philanthropub: Not Your Typical Noshery


Restaurateurs Nick Vilelle and Raj Ratwani are owners of the CAUSE gastropub, which includes a fresh menu, lively atmosphere, graffiti-inspired artwork, and a hefty beer list.






More Federal Domestic Assistance Programs


Native American Veteran Direct Loan Program | ARRA PREVENTING HEALTHCARE-ASSOCIATED INFECTIONS | Empowerment Zones Program | Regional Fishery Management Councils | Vocational and Educational Counseling for Servicemembers and Veterans |  Site Style by YAML | Grants.gov | Grants | Grants News | Sitemap | Privacy Policy


Edited by: Michael Saunders

© 2004-2024 Copyright Michael Saunders